Clinical Trial Update: Combined Therapy in Age-Related Macular Degeneration (ARMD) [Phase 4]

View source ↗

Summary

This report notes the completion of a Phase 4 clinical trial evaluating a combined therapy for age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Age-Related Macular Degeneration | Phase 4 | Status: COMPLETED